Ninety One (UK)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | – | Sell |
-812,021
| Closed | -$29.4M | – | 325 |
|
2016
Q4 | $29.4M | Sell |
812,021
-1,866,514
| -70% | -$67.7M | 0.15% | 137 |
|
2016
Q3 | $123M | Buy |
2,678,535
+235,821
| +10% | +$10.9M | 0.6% | 56 |
|
2016
Q2 | $123M | Buy |
2,442,714
+271,059
| +12% | +$13.6M | 0.63% | 56 |
|
2016
Q1 | $116M | Buy |
2,171,655
+1,148,997
| +112% | +$61.5M | 0.63% | 59 |
|
2015
Q4 | $67.1M | Buy |
1,022,658
+213,648
| +26% | +$14M | 0.38% | 87 |
|
2015
Q3 | $45.7M | Buy |
809,010
+199,442
| +33% | +$11.3M | 0.29% | 96 |
|
2015
Q2 | $36M | Sell |
609,568
-18,284
| -3% | -$1.08M | 0.21% | 117 |
|
2015
Q1 | $39.1M | Buy |
627,852
+47,332
| +8% | +$2.95M | 0.23% | 110 |
|
2014
Q4 | $33.4M | Sell |
580,520
-49,752
| -8% | -$2.86M | 0.2% | 115 |
|
2014
Q3 | $33.9M | Buy |
630,272
+6,382
| +1% | +$343K | 0.2% | 121 |
|
2014
Q2 | $32.7M | Sell |
623,890
-15,958
| -2% | -$837K | 0.19% | 130 |
|
2014
Q1 | $33.8M | Sell |
639,848
-8,514
| -1% | -$450K | 0.23% | 115 |
|
2013
Q4 | $26M | Buy |
648,362
+20,287
| +3% | +$813K | 0.18% | 117 |
|
2013
Q3 | $23.7M | Buy |
628,075
+4,345
| +0.7% | +$164K | 0.17% | 120 |
|
2013
Q2 | $24.5M | Buy |
+623,730
| New | +$24.5M | 0.19% | 123 |
|